STOCK TITAN

ProQR Therapeutics N.V. (PRQR) Free Cash Flow by Year

PRQR

ProQR Therapeutics N.V. recorded an outflow of $63.2M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters ProQR Therapeutics N.V. has filed alongside them.

FY2025 annual
Free Cash Flow -$63.2M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRQR Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Free Cash Flow-$63.2Mn/m-$39.1M-275.4%$22.3Mn/m-$74.0Mn/m-$30.0Mn/m-$58.7Mn/m-$50.0Mn/m-$33.0Mn/m-$42.2Mn/m-$38.8Mn/m-$27.7M

PRQR Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-KQ4'2320-FQ3'236-KQ2'236-KQ1'236-K
Free Cash Flow-$16.3Mn/m-$14.6Mn/m-$13.5Mn/m-$17.3Mn/m-$9.8Mn/m-$6.6Mn/m-$7.0Mn/m-$17.1M-135.3%-$6.6Mn/m-$8.3Mn/m-$11.6Mn/m$48.5Mn/m

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More ProQR Therapeutics N.V. financials

Frequently Asked Questions

What was ProQR Therapeutics N.V.'s free cash flow in fiscal year 2025?

ProQR Therapeutics N.V. recorded an outflow of $63.2M in free cash flow in fiscal year 2025.

How fast is ProQR Therapeutics N.V.'s free cash flow growing?

ProQR Therapeutics N.V. (PRQR) reported an outflow of $39.1M in free cash flow in fiscal year 2024 and an outflow of $63.2M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

How has ProQR Therapeutics N.V.'s free cash flow changed over the years?

Across the 11 fiscal years this page covers, ProQR Therapeutics N.V. (PRQR) free cash flow went from -$27.7M in fiscal year 2015 to -$63.2M in fiscal year 2025.

ProQR Therapeutics N.V. (PRQR) reported -$16.3M in free cash flow in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what ProQR Therapeutics N.V. (PRQR) reported on that line in every period on record.